Eculizumab vs placebo
Withdrawals due to any reason · patients with paroxysmal nocturnal hemoglobinuria
Eculizumab probably leads to lower withdrawal for any reason compared with placebo (moderate certainty).
1 finding from 1 review
- Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria 2014 · Cochrane Headline outcomes onlyRR 0.2 [0.05, 0.88]1 study · 87 participantsModerate